UHS launches Covid-19 drug trial at UoS.

SARGODHA -- As part of efforts to discover reliable treatment for Covid-19, the University of Health Sciences (UHS), Lahore, on Wednesday launched 'Landmark National Drug Trial: PROTECT' at University of Sargodha (UoS).

The trial named PROTECT (Pakistan Randomised Observational Trial to Evaluate Coronavirus Treatment) aims at evaluating how hydroxychloroquine can be used to treat coronavirus alone or with other medicines.

UHS Vice Chancellor Prof Dr Javed Akram briefed the meeting held at Syndicate Hall of UoS. The meeting was attended by Vice Chancellor Dr Ishtiaq Ahmad, Sargodha Medical College (SMC) Principal Dr Humaira Akram, MS DHQ Hospital Dr Ghulam Shabbir, and other senior medical specialists.

Sharing the final version of PROTECT with 550 subjects, the UHS VC claimed that the drug trial was the biggest trial being carried on Covid-19/SARS COV 2. In this research centre, doctors from across Pakistan and other countries will conduct research on the genotype of the virus along with the mutations in it.

Prof Dr Javed Akram briefed the meeting about the effectiveness of hydroxychloroquine phosphate/sulfate (200 mg orally 8hr thrice a day for...